Research Topics
| Terry M NolanSummaryAffiliation: University of Melbourne Country: Australia Publications
| Collaborators
|
Detail Information
Publications
The cost of community-managed viral respiratory illnesses in a cohort of healthy preschool-aged childrenStephen B Lambert
Vaccine and Immunisation Research Group, Murdoch Children s Research Institute, Royal Children s Hospital, and School of Population Health, University of Melbourne, Melbourne, Victoria, Australia
Respir Res 9:11. 2008..Despite their ubiquity, there is a lack of interdisciplinary epidemiologic and economic research that has collected primary impact data, particularly associated with indirect costs, from families during ARIs in children...- Making sense of perceptions of risk of diseases and vaccinations: a qualitative study combining models of health beliefs, decision-making and risk perceptionLyndal Bond
MRC CSO Social and Public Health Sciences Unit, Glasgow, UK
BMC Public Health 11:943. 2011..The aim of this study was to examine the utility of subjective risk perception and decision-making theories to provide a better understanding of the differences between immunisers' and non-immunisers' health beliefs and behaviours... - Comparison of three methods for ascertainment of contact information relevant to respiratory pathogen transmission in encounter networksJames M McCaw
Murdoch Childrens Research Institute, University of Melbourne, Parkville, Vic, Australia
BMC Infect Dis 10:166. 2010..We report on a pilot study designed to assess three different methods (one retrospective, two prospective) for obtaining contact data relevant to the determination of these mixing patterns... 
DTPa-HBV-IPV vaccine for primary vaccination of infantsTerry Nolan
Vaccine and Immunisation Research Group, Murdoch Childrens Research Institute and School of Population Health, University of Melbourne, Melbourne, Victoria, Australia
J Paediatr Child Health 43:587-92. 2007....- A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infantsTerry Nolan
Murdoch Children s Research Institute and School of Population Health, The University of Melbourne, Australia
Vaccine 25:8487-99. 2007..Hib-MenCY-TT administered according to the current US Hib vaccine schedule has the potential to induce protective antibodies against Hib and meningococcal-CY disease in infants and toddlers... 
Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of ageTerry Nolan
School of Population Health, University of Melbourne and Murdoch Children s Research Institute, Carlton, Melbourne, Victoria 3010, Australia
Pediatrics 121:508-16. 2008..This study evaluated the safety, tolerability, and immunogenicity of live attenuated influenza vaccine administered concurrently with measles-mumps-rubella vaccine and varicella vaccine to healthy children 12 to 15 months of age...- Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adultsTerry M Nolan
Murdoch Childrens Research Institute, and the Melbourne School of Population Health, University of Melbourne, Carlton, Victoria, Australia
Vaccine 26:4160-7. 2008..A secondary objective was to assess the cross-reactivity of immune responses to two variant clade 2 H5N1 strains... - Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and childrenTerry Nolan
Melbourne School of Population Health, The University of Melbourne, Victoria, Australia
Vaccine 26:6383-91. 2008..Our objective was to evaluate the safety and immunogenicity of a prototype inactivated, aluminium adjuvanted, split-virus, clade 1 H5N1 vaccine (A/Vietnam/1194/2004/NIBRG-14) in infants and children aged > or =6 months to < 9 years... - Booster vaccination of toddlers with reduced antigen content diphtheria -- tetanus -- acellular pertussis vaccineTerry Nolan
Murdoch Childrens Research Institute and Melbourne School of Population Health, The University of Melbourne, Victoria, Australia
Vaccine 27:2410-3. 2009.... - Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and childrenTerry Nolan
Vaccine and Immunisation Research Group at the Murdoch Children s Research Institute and the Melbourne School of Population Health, University of Melbourne, Victoria 3010, Australia
Influenza Other Respi Viruses 3:315-25. 2009..Our objective was to evaluate the safety, reactogenicity and immunogenicity of a thimerosal-free inactivated influenza vaccine (Fluvax; CSL Limited, Parkville, Australia) in children aged 6 months to <9 years... - Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trialTerry Nolan
Vaccine and Immunization Research Group, School of Population Health, University of Melbourne, and Murdoch Children s Research Institute, Victoria, Australia
JAMA 303:37-46. 2010..In the ongoing influenza pandemic, a safe and effective vaccine against 2009 influenza A(H1N1) is needed for infants and children... - The Australian model of immunization advice and vaccine fundingTerry M Nolan
Australian Technical Advisory Group on Immunisation, Head School of Population Health, University of Melbourne, Murdoch, Melbourne, Carlton 3010, Australia
Vaccine 28:A76-83. 2010.... - Immunogenicity and safety of an investigational combined haemophilus influenzae type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccineTerry Nolan
Vaccine and Immunisation Research Group, Murdoch Children s Research Institute and School of Population Health, University of Melbourne, Victoria, Australia
Pediatr Infect Dis J 30:190-6. 2011..Neisseria meningitidis serogroups B, C, and Y cause most meningococcal disease in industrialized countries. A Haemophilus influenzae type b-meningococcal serogroups C and Y-tetanus toxoid conjugate vaccine (HibMenCY-TT) was evaluated... - Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of ageTerry Nolan
School of Population Health, University of Melbourne, Victoria 3010, Australia
Pediatrics 118:e602-9. 2006.... - Antibody persistence, PRP-specific immune memory, and booster responses in infants immunised with a combination DTPa-HBV-IPV/Hib vaccineT Nolan
Murdoch Children s Research Institute, The University of Melbourne, VIC 3010, Australia
Vaccine 23:14-20. 2004..5% of booster recipients experienced >50-mm local swelling at the site of DTPa vaccination. We conclude that DTPa-HBV-IPV/Hib is safe and immunogenic for primary vaccination, and that Hib-specific memory is induced by primary vaccination... - Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccineTerry Nolan
The University of Melbourne, Department of Paediatrics, and Murdoch Children s Research Institute at the Royal Children s Hospital, Melbourne, Australia
Vaccine 21:281-9. 2002..This tetravalent MMRV candidate vaccine showed promising results, although further examination of the possible increase in minor fever and decreased varicella immunogenicity should be assessed in future studies... - Paediatric slow-speed non-traffic fatalities: Victoria, Australia, 1985-1995P Robinson
Public Health Branch, Department of Human Services, Victoria, Australia
Accid Anal Prev 29:731-7. 1997..These findings suggest some countermeasures, including the separation of vehicle driveways from children's play areas, and object vicinity ultrasonic warning devices for vehicles... - Immunisation uptake, services required and government incentives for users of formal day careL Bond
Centre for Adolescent Health, Royal Children s Hospital, Parkville, Victoria
Aust N Z J Public Health 23:368-76. 1999..To determine immunisation uptake in children attending formal day care prior to the introduction of certificates (state) and parent incentives (federal), and to document parent and child carers' attitudes to these strategies... - Randomised controlled trial of biofeedback training in persistent encopresis with anismusT Nolan
Melbourne University Department of Paediatrics, Royal Children s Hospital, Parkville Victoria, Australia
Arch Dis Child 79:131-5. 1998..Biofeedback training can be used to teach children to abolish this abnormal contraction... - Randomised controlled trial of an educational strategy to increase school-based adolescent hepatitis B vaccinationS R Skinner
Clinical Epidemiology and Biostatistics Unit, Royal Children s Hospital, Parkville, Victoria
Aust N Z J Public Health 24:298-304. 2000..This study aimed to evaluate a specifically designed hepatitis B education/promotion curriculum package as part of a successful hepatitis B vaccination delivery system to adolescents... - A combined liquid Hib (PRP-OMP), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: uncontrolled preliminary clinical trial of immunogenicity and reactogenicityT Nolan
Melbourne University Department of Paediatrics, Royal Children s Hospital, Australia
Vaccine 16:2085-9. 1998..This study has provided preliminary evidence for both the safety and immunogenicity of the pentavalent vaccine given as a course at 2, 4, 6 and 18 months... - A combined liquid Hib (PRP-OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: controlled studies of immunogenicity and reactogenicityT Nolan
Clinical Epidemiology and Biostatistics Unit, Melbourne University Department of Paediatrics at the Royal Children s Hospital and Murdoch Children s Research Institute, Vic, 3052, Parkville, Australia
Vaccine 19:2127-37. 2001..A regimen of a birth dose of hepatitis B vaccine followed by pentavalent vaccine at 2, 4, 6 and 18 months was not countered by any clinically significant decrease in seroresponses... - Immunogenicity and reactogenicity associated with an 18-month booster dose of a new diphtheria-tetanus-whole cell pertussis vaccineT Nolan
Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia
J Paediatr Child Health 34:346-8. 1998..To establish safety and immunogenicity of a reformulated whole cell pertussis based diphtheria-tetanus-pertussis vaccine (DTPw) at the 18-month booster stage following a 2, 4, and 6-month primary immunization course... - Vaccine preventable diseases and immunisations: a qualitative study of mothers' perceptions of severity, susceptibility, benefits and barriersL Bond
Dept of Paediatrics, University of Melbourne, Royal Children s Hospital, Parkville
Aust N Z J Public Health 22:441-6. 1998..This study found that many mothers were balancing the risks of immunising with the risks of not immunising and this must be taken into account, along with factors such as difficulties in obtaining immunisations... - Measles-mumps-rubella and hepatitis B vaccination uptake in adolescents: a survey in metropolitan MelbourneS R Skinner
Royal Children s Hospital, Melbourne, Vic
Med J Aust 168:546-9. 1998..To measure the uptake of preadolescent measles-mumps-rubella (MMR) and adolescent hepatitis B vaccinations and assess the influence of certain demographic factors on the uptake of these vaccines... - Understanding Australia's influenza pandemic policy on the strategic use of the antiviral drug stockpileJames M McCaw
Vaccine and Immunisation Research Group, Melbourne School of Population Health, University of Melbourne and Murdoch Childrens Research Institute, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Vic, Australia
Med J Aust 191:136-7. 2009..Targeted post-exposure prophylaxis represents a more efficient use of the stockpile than treatment alone... - A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4-6 yearsH Marshall
Department of Paediatrics, Children s Youth and Women s Health Service and University of Adelaide, SA, Australia
Vaccine 24:6120-8. 2006..This combined DTPa-IPV vaccine has a similar reactogenicity profile to DTPa, is immunogenic when given as a booster dose at 4-6 years of age, and has no impact on the immunogenicity of a co-administered second dose of MMR vaccine... - Quality of hospital care for seriously ill children in less-developed countriesT Nolan
Department of Paediatrics, University of Melbourne and Murdock Children's Research Institute, Royal Children's Hospital, Parkville, Australia
Lancet 357:106-10. 2001..Possible targets for improvement include initial triage, emergency care, assessment, inpatient treatment, and monitoring. Priority targets for individual hospitals may be determined by assessing each hospital... - Risk-factors for meningococcal disease in Victoria, Australia, in 1997P Robinson
Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute/Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Victoria
Epidemiol Infect 127:261-8. 2001..Besides confirming some previously identified risk factors, this is the first time that snoring and speech problems have been identified as risk factors for meningococcal disease... - Randomized, double-blind study comparing the efficacy of moderate-dose metoclopramide and ondansetron for the prophylactic control of postoperative vomiting in children after tonsillectomyC M Bolton
Department of Anaesthesia and Pain Management, University of Melbourne, Royal Children s Hospital, Murdoch Children s Research Institute, Flemington Road, Parkville, Melbourne 3052, Australia
Br J Anaesth 99:699-703. 2007..It has been suggested that at moderate doses (0.5 mg kg(-1)), metoclopramide is also an effective agent. No study has been performed comparing the efficacy of an anti-serotinergic agent and moderate-dose metoclopramide... - Laboratory enhanced surveillance for meningococcal disease in VictoriaP Robinson
Department of Human Services, Victoria, Melbourne, Australia
J Paediatr Child Health 37:S7-12. 2001..To describe the epidemiological and microbiological characteristics and notification patterns of invasive meningococcal disease (IMD) in Victoria between 1990 and 1999... - Twelve year outcomes following bacterial meningitis: further evidence for persisting effectsK Grimwood
Department of Paediatrics, University of Melbourne, Melbourne, Australia
Arch Dis Child 83:111-6. 2000..To determine whether intellectual and cognitive impairments observed seven years following early childhood bacterial meningitis persist into adolescence...